Scottish remote sensor specialist Novosound has secured a seven-figure research and development (R&D) licensing deal with Israeli company dSound.
The contract is to deliver 3D ultrasound technology to the dental imaging market, enabling dentists to look safely at patients' teeth and bones.
Novosound is currently in the process of hiring a number of software engineers who specialise in 3D imaging to help deliver its ultrasonic platform.
Founded in 2018, Novosound’s patented thin-film manufacturing process, which eliminates conventional limitations in ultrasound sensors - including the high cost of high-resolution imaging - also underpins the company’s pioneering non-destructive testing (NDT) products.
The company was the first spin-out from the University of the West of Scotland, and recently secured contracts with aerospace giants BAE Systems and GE Aviation.
Novosound chief executive and co-founder Dave Hughes said: “Dentistry is currently undergoing digitisation with the emergence of new advanced imaging techniques, and we see scope for our high-resolution ultrasonic technology to make a big impression, first in dental but then across other segments of the global 3D medical imaging market.
“One of my academic projects that inspired the founding of Novosound was a collaboration with Current Health’s Chris McCann - this was back in 2016 at the University of the West of Scotland, when we secured early-stage R&D grant funding to develop an ultrasound sensor for a medical device to monitor patient hydration levels.”
Last year, the company appointed Dr Derek Mathieson, former chief marketing and technology officer at Baker Hughes, as its chairman, and former BGF investment director Duncan Macrae, as chief financial officer.
In December 2019, Novosound secured £3.3m funding, in a round led by Foresight Group.
Don't miss the latest headlines with our twice-daily newsletter - sign up here for free.
